期刊文献+

表皮生长因子受体、Her-2、血管内皮生长因子在子宫颈上皮内瘤变和鳞状细胞癌中的表达及意义 被引量:1

Significance of EGFR, Her-2 and VEGF expressions in cervical intraepithelial neoplasia and squamous cell carcinoma
原文传递
导出
摘要 目的 探讨表皮生长因子受体(EGFR)、Her-2、血管内皮生长因子(VEGF)在子宫颈鳞状上皮内瘤变及子宫颈鳞状细胞癌组织中的表达,以及其在子宫颈鳞状细胞癌发生、发展及转移中的意义.方法 采用免疫组织化学法检测10例正常子宫颈组织、40例子宫颈鳞状上皮内瘤变、50例子宫颈鳞状细胞癌组织中EGFR、Her-2 、VEGF的表达情况.结果 EGFR、Her-2、VEGF在正常子宫颈组织中均无阳性表达,而在子宫颈上皮内瘤变中的阳性表达率分别为35.0%(14/40)、37.5%(15/40)、42.5%(17/40),在鳞状细胞癌中的阳性表达率分别为70.0%(35/50)、78.0%(39/50)、76.0%(38/50),差异有统计学意义(P< 0.01);EGFR、Her-2、VEGF的表达与子宫颈鳞状细胞癌的组织学分级及淋巴结转移密切相关,而且Her-2、VEGF的表达与子宫颈鳞状细胞癌的临床分期相关.结论 EGFR、Her-2、VEGF可能参与了子宫颈癌的发生,并在子宫颈癌的发展和转移中起重要作用,可作为评价子宫颈癌恶性程度的指标. Objective To investigate the expressions of EGFR,Her-2 and VEGF in cervical intraepithelial neoplasia (CIN) and cervical squamous cell carcinoma,as well as its clinic value of carcinogenesis,progression and metastasis in ccrvical squamous cell carcinoma.Methods EGFR,Her-2 and VEGF were evaluated by immunohistochemistry in tissues from normal cervix,CIN and squamous cell carcinoma.Results The expressions of EGFR,Her-2 and VEGF were negative in normal cervix.The positive rate of EGFR,Her-2 and VEGF in CIN tissues were 35.0 % (14/40),37.5 % (15/40),42.5 % (17/40),while in cervical carcinoma tissues were 70.0 % (35/50),78.0 % (39/50),76.0 % (38/50) respectively,which had statistical significance.There was relationship between the expressions of EGFR,Her-2,VEGF proteins with pathological grade andlymph node metastasis of squamous cell carcinoma.The expressions of Her-2 and VEGF correlated with the clinical stage of quamous cell carcinoma.Conclusion The expressions of EGFR,Her-2 and VEGF may be correlated with the occurrence,development and metastasis of cervical carcinoma.It may be used as an important marker to evaluate the malignant degree of cervical carcinoma and it can be helpful in the treatment of cervical carcinoma.
机构地区 [
出处 《肿瘤研究与临床》 CAS 2013年第11期750-753,共4页 Cancer Research and Clinic
关键词 受体 表皮生长因子 HER-2 血管内皮生长因子 子宫颈上皮内瘤样病变 子宫颈肿瘤 Receptor, epidermal growen factor Her-2 Vascular endothelial growth factor Cervical intraepithelial neoplasia Uterine cervical neoplasms
  • 相关文献

参考文献13

二级参考文献62

  • 1Qiao Qiao CHEN,Xiao Ying CHEN,Yun Yun JIANG,Jing LIU.Identification of novel nuclear localization signal within the ErbB-2 protein[J].Cell Research,2005,15(7):504-510. 被引量:9
  • 2张凯丽,王树峰,问明,郑宝恒,底旺,李艳玉.Syk与C-erbB-2、PCNA在乳腺癌中的表达及意义[J].中国肿瘤,2006,15(2):131-133. 被引量:3
  • 3Folkman J. What is the evidence that tumors are angiogenesis dependent? Natl Cancer Inst,1990,92:4-6. 被引量:1
  • 4Ferrara N, Gerber HP, Couter J. The biology of VEGF and its receptors.Nat Med,2003,9:669-676. 被引量:1
  • 5Ferrara N,Henzel WJ.Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biophys Res Commun,1989,161:851-858. 被引量:1
  • 6Hyder SM,Murthy L, Stancel GM.Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res,1998,58:392-395. 被引量:1
  • 7Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.EMBO J,1999,18:3964. 被引量:1
  • 8Li CY,Shan S,Huang Q,et al.Initial stage of tumor cell-induced angiogenesis:evaluation via skin window chambers in rodent models.J Natl Cancer Inst(Bethesda),2000,92:143. 被引量:1
  • 9Rosen LS. Clinical experience with angiogenesis signaling inhibitors:focus on vascular endothelial growth factor (VEGF) blocker. Cancer Control,2002,9:36. 被引量:1
  • 10Snith WL,deWitt DL,Garavito RM.COX:structural,cellular,and molecular biology.Rev Biochem,2000,69:145-182. 被引量:1

共引文献28

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部